CClinicalTrials.gg
RecruitingNCT07629739iSTEP-2Updated Jul 23, 2026

Inspiring Seniors Towards Exercise Promotion - 2

An interventional study of Exercise intervention with RAS (EX+RAS) and Exercise intervention without RAS (EX) in Old Age, sponsored by Emory University. Recruiting at 1 site in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-23.

Sponsored by Emory University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started May 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Older adults' low adherence to the national physical activity guidelines may stem from a failure to increase positive affective responses to exercise (e.g., enjoyment). Exercising with personalized, tempo-synchronous music playlists has shown promising effects on physical activity promotion in midlife-to-older adults during a cardiac rehab program. The purpose of this study is to determine how personalized, tempo-synchronous music playlists called rhythmic auditory stimulation (RAS) influence exercise behavior change and affective responses to exercise over 8 months among community-dwelling, sedentary older adults.

Read the detailed description

Participants 65 years and older will be offered an exercise program for six months, either with or without RAS. The exercise program is based on the national physical activity guidelines for older adults and designed to train participants to independently engage in strength training and moderate-intensity aerobic training through the gradual withdrawal of supervised exercise classes (2 days/week for 3 months and 1 day/week for an additional 3 months). At baseline, every month during the 6-month intervention, and 2-month post-intervention follow-up, we assess weekly volume of physical activity (primary outcome) using a hip-worn activity tracker and affective attitude toward physical activity (mechanistic outcome) through text-message-based ecological momentary assessment (EMA). Before and after the 6-month intervention, participants will complete a lab visit for the assessment of cognitive, vascular, and physical functioning, fitness, anthropometry, and quality of life.

02

Conditions studied

  • Old Age

Browse trials for

Keywords

  • Physical Activity
  • Exercise
  • Music
  • Cognitive decline prevention
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's planned enrollment of 150 is above the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Emory University is the lead sponsor of 1,386 studies on the registry; 236 are open to participants now.

Of its 229 completed or terminated interventional studies of FDA-regulated products, 174 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adults over 65 years old.
  • Ambulatory without pain or the use of assisted walking devices.
  • Able to speak and read English.
  • Healthy enough to exercise at moderate intensity with or without medical clearance by a primary care physician.
  • Living in the community for the duration of the study (9-10 months).
  • Having a reliable means of transportation.
  • Having a safe place at home or at a residential area (at least 6 feet by 6 feet of open space) for unsupervised exercise training.
  • Being low-active (\< 90 min/week of MAT and \< 2 days/week of ST for the last 3 months).

Exclusion criteria

Exclusion Criteria:

  • Diagnosed progressive, neurodegenerative, or severe central nervous system disorders (e.g., Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, or history of stroke with residual deficits) that significantly impair cognitive function, motor skills, or the ability to engage in independent exercise training over moderate intensity
  • Participants with a history of episodic or peripheral neurological conditions (such as neuralgia or migraines) or stable cardiovascular/metabolic conditions may be included if they receive formal written medical clearance from their primary care physician or treating specialist, confirming it is safe for them to engage in unsupervised exercise training at moderate intensity.
  • Known exercise contraindications (uncontrolled hypertension, joint problems, diabetes, metabolic conditions, etc.), determined by self-report on the PAR-Q+.
  • Current or upcoming cancer treatment, determined by self-report on the PAR-Q+.
  • Stroke or neural impairment in the past 6 months, as self-reported on the PAR-Q+.
  • Hip/knee/spinal fracture or surgery in the past 6 months, determined by self-report on the ACSM Health Screening Questionnaire.
  • Unable or unwilling to attend intervention classes, as determined by phone screening.
  • Currently participating in any other exercise or fitness-related research study, determined by phone screening.
  • Use of medications for cognitive impairment, as self-reported on the medication survey.
  • Initiation or change in dosage of psychiatric medications (e.g., antidepressants, anxiolytics) within the past 8 weeks; participants must be on a stable dose for at least 2 months before enrollment and intend to maintain this dose throughout the 8-month study period.
  • Self-report regularly drinking > 14 alcoholic beverages a week or current illicit drug use, determined by self-report to screening surveys.
  • Current regular or hazardous use of illicit substances, or misuse of prescription medications, that occurs on a weekly or more frequent basis, or any substance use that, in the judgment of the investigator, would systematically confound weekly affective assessments or compromise safety during unsupervised exercise training, determined by self-report to screening surveys
  • Cannot ambulate without a walker/cane, assessed in the American College of Sports Medicine (ACSM) Health Screening Questionnaire
  • Having cognitive impairment, determined by the Montreal Cognitive Assessment (MoCA) BLIND \< 17.
  • Meet the threshold for clinical depression, determined by the Center for Epidemiological Studies Depression Scale Revised (CESD-R).
  • Uncorrected hearing or visual impairments, self-reported on the Health History Questionnaire.
  • Unable to understand the study procedure.
  • One of the household members is participating in this study, as self-reported during phone screening.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Exercise intervention with RAS (EX+RAS)

    Participants will be randomized to an exercise intervention with RAS (EX+RAS) over 6 months, offering the exercise prescription to foster independent adherence to the Physical Activity guidelines (PAG) through the gradual withdrawal of supervised training. This group will be provided with RAS playlists and trained to use them for their exercise sessions.

    Behavioral: Exercise intervention with RAS (EX+RAS)

  • Active comparator
    Exercise intervention without RAS (EX)

    Participants will be randomized to an exercise intervention (EX) over 6 months, offering the same exercise prescription as the experimental group, to foster independent adherence to the PAG through the gradual withdrawal of supervised training. This group will not be provided with any RAS playlists to accompany their exercise.

    Behavioral: Exercise intervention without RAS (EX)

Interventions

  • BehavioralExercise intervention with RAS (EX+RAS)

    Supervised exercise sessions will be led by an exercise specialist at an open-floor gym. All participants will be asked to attend a supervised group exercise session for moderate aerobic training (MAT) for 15-40 minutes/day and muscle-strengthening training (ST) for 15-20 minutes/day for 2 days/week for the first 3 months, while being encouraged to independently perform MAT on up to 3 more days/week. Then, the same training session will be offered for 1 day/week for an additional 3 months while encouraging participants to independently perform ST on 1 more day of the week and MAT up to 4 more days of the week. Participants will be instructed on set and track exercise goals, supplemented with a series of behavioral supports during the 6-month intervention and until a 2-month post-intervention follow-up.

  • BehavioralExercise intervention without RAS (EX)

    Supervised exercise sessions will be led by an exercise specialist at an open-floor gym. All participants will be asked to attend a supervised group exercise session for moderate aerobic training (MAT) for 15-40 minutes/day and muscle-strengthening training (ST) for 15-20 minutes/day for 2 days/week for the first 3 months, while being encouraged to independently perform MAT on up to 3 more days/week. Then, the same training session will be offered for 1 day/week for an additional 3 months while encouraging participants to independently perform ST on 1 more day of the week and MAT up to 4 more days of the week. Participants will be instructed on set and track exercise goals, supplemented with a series of behavioral supports during the 6-month intervention and until a 2-month post-intervention follow-up.

06

What researchers measure

Primary outcomes

  1. Weekly volume of light, moderate, and vigorous physical activity as assessed by ActiGraph

    Duration, intensity, and frequency of physical activity will be assessed using a waist-worn accelerometer.

    Time frame: 7 consecutive days at Baseline (before the intervention) and during month 1, 2, 3, 4, 5, and 6 (during intervention) and month 8 (2 months post-intervention)

  2. Daily duration of aerobic and strenght training as recorded on an Exercise Log

    Self-reported daily duration and types of physical activity will be self-reported on an exercise log.

    Time frame: During month 1, 2, 3, 4, 5, 6, 7 (during the intervention) and month 8 (2 months post - intervention until 2-month post-intervention)

  3. Affective response to exercise measured by the single-item Feeling Scale (FS)

    The single-item Feeling Scale (FS) will be used to measure affective responses to physical activity as assessed by Ecological Momentary Assessment (EMA). How are you feeling right now? with 11-point rating scale scores ranging from -5 to +5, with labels -5 = very bad, -3 = bad, -1 = somewhat bad, 0 = neutral, +1 = somewhat good, +3 = good, and +5 = very good.

    Time frame: For 3 days at Baseline (before the intervention), weekly during month 1, 2, 3, 4, 5, and 6 (during intervention), and for 3 days in month 8 (2 months post-intervention)

Secondary outcomes

  1. Perceived exertion measured by the Borg's Rating of Perceived Exertion (RPE) scale

    Borg's Rating of Perceived Exertion (RPE) scale will be used to assess perceived exertion during physical activity as assessed by Ecological Momentary Assessment (EMA). Scores range from 6 to 20, with verbal anchors of 7 = very, very light, 9 = very light, 11 = fairly light, 13 = somewhat hard, 15 = hard, 17 = very hard, and 19 = very, very hard.

    Time frame: For 3 days at Baseline (before the intervention), weekly during month 1, 2, 3, 4, 5, and 6 (during intervention), and for 3 days in month 8 (2 months post-intervention)

  2. Subjective cognitive decline measured by the Cognitive Change Index (CCI-12)

    The Cognitive Change Index (CCI-12) is a 12-item questionnaire assessing self or informant-perceived decline in episodic memory over the past 5 years. It uses a 5-point Likert scale (1=no change, 5=much worse), with higher total scores (range 12-60) indicating greater perceived decline. It acts as a marker for dementia risk, subjective cognitive decline (SCD), and early Alzheimer's. The CCI-12 ranges from 12 to 60. Higher scores signify greater perceived decline.

    Time frame: At pre-test (before the intervention) and 6 weeks post-intervention

  3. Exercise motivation measured by the Behavioural Regulation in Exercise Questionnaire-3 (BREQ-3)

    The Behavioural Regulation in Exercise Questionnaire-3 (BREQ-3) is a 19 to 24-item tool (commonly 23-24 items) used to assess motivation for physical activity based on Self-Determination Theory. It measures six types of motivation, ranging from not at all motivated to intrinsically motivated,. Likert Scale Range: 0 to 4 (0 = "Not true for me", 4 = "Very true for me"). Higher average scores (closer to 4) indicate that a particular regulation style is a strong reason for exercising.

    Time frame: Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)

  4. Affective attitude toward physical activity measured by the Physical Activity Enjoyment Scale (PACES)

    Physical Activity Enjoyment Scale (PACES) to assess affective attitude toward PA. Self-reported affective states relative to physical activity. The Physical Activity Enjoyment Scale has 18 items on a 7-point Likert scale, and the total score ranges from 18 to 126. A total score of 63 can be used to distinguish between enjoyment (\>63) and lack of enjoyment (\<63).

    Time frame: Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)

  5. Individual confidence in regular exercise measured by the Self-Efficacy for Exercise Scale (SEE)

    Self-Efficacy for Exercise Scale (SEE) is a self-report tool used to measure an individual's confidence in their ability to perform exercises regularly (e.g., 3 times per week for 20+ minutes) despite common barriers. The scale consists of 9 items. Scale: Each item is rated on an 11-point Likert scale ranging from 0 (Not Confident) to 10 (Very Confident). Minimum Score: 0 (representing zero confidence). Maximum Score: 90 (representing maximum confidence). Total Score Calculation: The total score is calculated by summing the responses to all 9 items. A higher total score indicates higher self-efficacy for exercise. 0-30: Low self-efficacy (low confidence in overcoming barriers to exercise). 31-60: Moderate self-efficacy. 61-90: High self-efficacy (high confidence in maintaining an exercise routine).

    Time frame: Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)

  6. Individual barriers in regular exercise measured by Barriers to Being Active survey (BBA)

    The Barriers to Being Active (BBA) survey is a 21-item questionnaire developed by the Centers for Disease Control and Prevention (CDC) to identify personal obstacles to exercise. It measures seven distinct categories of barriers, with each category containing 3 items. Each of the 21 questions is rated on a 4-point Likert scale: Very likely (3 points), Somewhat likely (2 points), Somewhat unlikely (1 point), Very unlikely (0 points). Since there are 3 questions per category, the minimum score is 0, and the maximum score is 9 per barrier. The minimum total score is 0, and the maximum total score is 63 (21 items × 3 points). Significant Barrier: A score of 5 or higher in any of the seven categories indicates that it is an important barrier to overcome. Low Barrier: A score below 5 indicates the barrier is less significant.

    Time frame: Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)

  7. Physical activity and sedentary behaviors measured by Physical and Sedentary Behaviour Questionnaire (PASB-Q)

    The Physical and Sedentary Behaviour Questionnaire (PASB-Q) is a tool used to assess an adult's typical weekly physical activity, muscle strengthening, and sedentary habits. It is not a single standardized 0-100 score, but rather a questionnaire that measures specific behaviors and can be used to gauge whether an individual meets physical activity guidelines. The questionnaire measures several aspects of physical activity. There is no set "maximum" score, as it measures frequency and duration, but the "minimum" is 0. It calculates the total minutes of moderate-to-vigorous aerobic physical activity per week. Minutes/day = Total Minutes/Week. Interpretation: Higher minutes per week indicate higher activity levels.

    Time frame: At pre-test (before the intervention) and post-test within 6 weeks after the intervention

  8. Health-related quality of life measured by RAND 36-item Health Survey (RAND-36)

    RAND 36-item Health Survey (RAND-36) to assess health-related quality of life. The RAND 36-Item Short-Form Health Survey Scale has 36 items for self-report, takes 10-15 minutes to complete, and measures health-related quality of life with a score ranging from 0 to 100, where 0 indicates the lowest possible health state (worst health), and 100 indicates the highest possible health state (best health). Higher scores always represent better health status.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  9. Sleep disturbance measured by the Pittsburgh Sleep Quality Index (PSQI)

    The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire used to evaluate sleep quality over a one-month interval. It measures seven components of sleep, with a total global score ranging from 0 to 21. Minimum Score: 0 (Indicates no difficulty/excellent sleep quality).Maximum Score: 21 (Indicates severe difficulties in all areas/very poor sleep quality). Higher Score = Worse Sleep: A higher total score indicates poorer sleep quality. Scoring of 5: "Good" sleeper (low level of sleep disturbance) and \> 5: "Poor" sleeper (indicates significant, relevant sleep disturbances)

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  10. Depression measured by the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R)

    The Center for Epidemiologic Studies Depression Scale-Revised (CESD-R) is a 20-item self-report questionnaire designed to measure the frequency and severity of depressive symptoms over the past two weeks. It is used to identify individuals who may need a further clinical evaluation for depression. Minimum Score (0): Indicates that the individual experienced almost no depressive symptoms, or that symptoms were present for less than one day, over the past two weeks. Maximum Score (80): Indicates high frequency and severity, suggesting all 20 symptoms were present nearly every day for the past two weeks. Total Score Range: The CESD-R uses a 5-point scale (0 to 4 per item), resulting in a total range of 0 to 80. A total score of \>=16 or \>= 17 generally indicates a risk for clinical depression or significant depressive symptoms.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  11. Perceived stress measured by the NIH Toolbox Perceived Stress Scale (PSS).

    The NIH Toolbox Perceived Stress Scale (PSS) is a 10-item self-report questionnaire designed to measure how unpredictable, uncontrollable, and overloaded a person finds their life to be over the past month. The PSS is part of the NIH Toolbox Emotion Battery. Minimum Score (0): Indicates no perceived stress. Maximum Score (40): Indicates very high perceived stress. Calculation: Responses are scored on a scale of 0 (Never) to 4 (Very Often). Four positive items are reversed (0=4, 1=3, 2=2, 3=1, 4=0) before summing all 10 items for a total score. 0-13 (Low Stress): Below-average stress, generally feel in control. 14-26 (Moderate Stress): Average stress level, manageable but may warrant attention. 27-40 (High Stress): Elevated, high stress, often associated with poorer health outcomes.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  12. Arterial fitness (carotid-femoral pulse wave velocity) as measured by the SphygmoCor XCEL system

    The SphygmoCor XCEL system provides measurements on pulse wave velocity, which will serve as the outcome of interest in arterial fitness. It is measured in units of meters per second, at which blood pressure waves travel through the circulatory system.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  13. Central aortic blood pressure (systolic and diastolic, mmHg) as measured by the SphygmoCor XCEL system

    Central aortic pressure measures blood pressure directly at the root of the aorta, and is measured in units of millimeters of mercury (mmHg).

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  14. Body Weight

    Measurements will be taken using the InBody380 scan.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  15. Skeletal muscle mass

    Skeletal muscle mass will be measured using the InBody380 scan.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  16. Body fat percentage

    Body fat percentage (percent body fat) will be measured using the InBody380 scan.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  17. Music-related reward experiences measured by the Barcelona Music Reward Questionnaire (BMRQ) to assess music-related reward experiences

    The Barcelona Music Reward Questionnaire (BMRQ) assesses music-related reward experiences. It consists of 20 items rated from 1 (completely disagree) to 5 (completely agree), with scores ranging from 0 to 100. Musical Anhedonia (Low): \<= 65. These individuals derive little to no pleasure from music despite having normal hearing and cognitive function. Average/Normal Reward: 66 - 86. The majority of the population falls within this middle range. Hyperhedonia (High): \>= 87. These individuals experience unusually strong emotional or physical responses to music.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  18. Sagittal abdominal diameter

    Measurements will be taken using a standardized anthropometric protocol (abdominal caliper)

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  19. Waist circumference

    Measurements will be taken using a standardized anthropometric protocol (abdominal caliper)

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  20. Hip circumference

    Measurements will be taken using a standardized anthropometric protocol (abdominal caliper)

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  21. Leg circumference

    Measurements will be taken using a standardized anthropometric protocol (abdominal caliper)

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  22. The auditory stimulation score

    Auditory stimulation score as assessed by a 10-item custom-developed Playlist Rating survey Developed by the research team, this 10-item survey assesses the extent to which audio and video playlists motivate individuals in strength and aerobic training. Items are scored on a Likert-based scale (1=Strongly disagree, 7=Strongly agree). Scores are stratified by method of playlist administration (i.e., audio and video) and then summed, where higher scores represent higher levels of auditory stimulation. The total score ranges from 5 to 35 for aerobic and strength training, with higher scores indicating greater auditory stimulation.

    Time frame: During month 3 and 6 (during intervention) and 8 months (2 months post-intervention)

  23. Gait speed at normal and brisk pace (meters/second) as assessed by the 10-Meter Walk Test (10MWT)

    The 10-meter walk test (10MWT) assesses gait speed by timing a patient walking a 6-meter distance, usually within a 10-meter path to allow for acceleration/deceleration. It is a standardized assessment for gait by measuring the time taken at the 2m and 8m markers during the timed, steady-state portion. This outcome measure reports gait speed in meters per second (m/s) at normal and brisk pace.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  24. Aerobic fitness as assessed by the total distance walked in 6-minute walk test

    The distance in meters covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  25. Hand Grip Strength

    Hand Grip Strength as measured by a Jamar hand dynamometer. The squeeze power in kilograms is measured by a handheld Jamar dynamometer.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  26. The progress of balance as assessed by 4-Stage Balance Test

    Standing balance (time held, in seconds) as assessed by the 4-Stage Balance Test. The duration in seconds of maintaining 4 difference postures.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

  27. Lower-body strength as assessed by 30-Second Sit-to-Stand test

    The number of sit-to-stand maneuvers completed in 30 seconds.

    Time frame: At pre-test (before the intervention) and post-test, within 6 weeks after the intervention

  28. The progress of balance, sit-to-stand, and walking as assessed by Timed Up and Go test

    The time taken to complete a Timed Up and Go test is an indicator of fall risks.

    Time frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention

07

Study locations

1 of 1 sites recruiting
  • Emory University
    Atlanta, Georgia 30329, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Researchers will share individual deidentified participant data that underlie the results reported from this trial (text, tables, figures, and appendices).

Supporting information: Study protocol, Sap, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07629739
Lead sponsor
Emory University
Collaborators
National Institute on Aging (NIA)
Responsible party
Kyoung Shin Park, PhD (Assistant Professor, Emory University) — Principal investigator
First posted
Jun 5, 2026
Start date
May 26, 2026
Primary completion
Aug 31, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Jul 23, 2026

Study contacts

Kaetlin Marsh, MPH
Contact
kaetlin.marsh@emory.edu
404-544-2381
Kyoung Shin Park, PhD
principal investigator · Emory University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion